Data Analysis and Coordination Center for the PsychENCODE Consortium (U24 Clinical Trial Not Allowed) | PAR 23 234

Frequently Asked Questions (FAQs) - NIH PAR-23-234 (PsychENCODE DACC U24)

What is the funding opportunity number and what does it support?

The opportunity is NIH PAR-23-234. It invites applications for a U24 cooperative agreement to operate the Data Analysis and Coordination Center (DACC) for the PsychENCODE Consortium.

What is the DACC (Data Analysis and Coordination Center) expected to be?

The DACC is intended to serve as a central, consortium-wide hub that coordinates, manages, and analyzes large and complex functional genomics datasets related to the human brain across the PsychENCODE Consortium.

What is the overall purpose of this award?

The purpose is to enable large-scale coordination and high-quality data integration and analysis across PsychENCODE, with an emphasis on uncovering and interpreting human-specific non-coding regulatory elements and making consortium data and outputs broadly usable and accessible.

What scientific focus does the FOA emphasize?

A central emphasis is on human-specific non-coding regulatory elements: genomic regions that do not encode proteins but can strongly influence when, where, and how genes are turned on or off. The FOA highlights their importance across brain regions, cell types, and developmental stages for understanding the molecular basis of psychiatric disorders.

What kinds of data are involved?

The opportunity references large, complex functional genomics datasets tied to the human brain and the need to integrate and harmonize data generated across the PsychENCODE Consortium.

What does "coordination at scale" mean in this context?

It means the DACC is expected to support consortium-wide integration and harmonization so that disparate datasets can be put into consistent formats and shared standards, enabling reliable comparison and combination across studies and modalities.

What does data harmonization and integration involve for the DACC?

Based on the provided description, harmonization and integration typically include bringing datasets into consistent formats and shared standards, supporting metadata standardization, and ensuring datasets can be linked across experiments and modalities.

What analysis and data workflow responsibilities are implied for the DACC?

The DACC is expected to enable high-quality analysis workflows and data management practices. Practical examples mentioned include developing and maintaining pipelines for processing and quality control, and producing accessible releases to the research community.

How does the DACC support PsychENCODE's goals related to psychiatric disorders?

By integrating and analyzing multi-dimensional brain functional genomics data, the DACC would be positioned to support analyses that connect regulatory DNA and RNA features to cell-type-specific function, developmental timing, and disease-relevant molecular signatures that inform the biology underlying psychiatric disorders.

What type of NIH award mechanism is this?

This is a cooperative agreement (U24).

What does a "cooperative agreement (U24)" imply about NIH involvement?

It signals that NIH expects substantial scientific and programmatic involvement compared with a standard research grant. The DACC would work in close partnership with NIH and the PsychENCODE Consortium to meet shared milestones, coordinate priorities, and align deliverables.

Are clinical trials allowed under this funding opportunity?

No. The FOA is explicitly labeled "Clinical Trial Not Allowed," meaning the supported work should not involve conducting clinical trials.

Who is the awarding agency?

The awarding agency is the National Institutes of Health (NIH).

What is the activity category and assistance listing (CFDA) number?

The activity category is health, and the listing is associated with CFDA number 93.242.

What organizations are eligible to apply?

Eligibility is limited. Eligible applicants include public and state-controlled institutions of higher education.

Are foreign (non-U.S.) institutions eligible to apply?

No. Non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply.

Can a U.S. organization apply if it has a non-domestic component?

No. Non-domestic components of U.S. organizations are not eligible to apply.

Are any foreign collaborations allowed at all?

Yes, "foreign components" as defined in the NIH Grants Policy Statement are allowed. This generally means a U.S.-based applicant may include certain foreign activities or collaborations if they meet NIH definitions and are appropriately justified and approved. Applicants are directed to consult the full NOFO for the precise definitions and requirements.

Where should applicants confirm detailed eligibility definitions and rules?

Applicants should consult the full Notice of Funding Opportunity (NOFO), especially for details on what qualifies as a foreign component versus a foreign institution applicant.

When was this opportunity created and what was the original closing date?

The opportunity was created on June 29, 2023, and the original closing date was August 24, 2023.

What is the funding instrument type and category?

The funding instrument type is a cooperative agreement, and the opportunity falls under the discretionary category.

Does the provided synopsis include the award ceiling or expected number of awards?

No. The public synopsis fields provided do not include a specific award ceiling or expected number of awards. Those details would need to be confirmed in the full NOFO or related NIH documentation.

What is the main takeaway of PAR-23-234?

PAR-23-234 is designed to fund a central, consortium-facing data and analysis organization that improves the usability, interoperability, and impact of PsychENCODE data by integrating, harmonizing, analyzing, and disseminating consortium outputs, with a strong emphasis on human-specific non-coding regulatory mechanisms relevant to psychiatric disorders.